Article
Survival advantage of heterozygous factor V Leiden carriers in murine sepsis.
Journal of thrombosis and haemostasis : JTH - 1 Jun 2015
Kerschen E, Hernandez I, Zogg M, Maas M, Weiler H
Abstract excerpt
BACKGROUND: The high allelic frequency of the prothrombotic Leiden polymorphism in human blood coagulation factor V (FV) has been speculated to reflect positive selection during evolution. Heterozygous Leiden carriers enrolled in the placebo arm of the PROWESS sepsis trial and heterozygous Leiden mice challenged with endotoxin both showed reduced mortality, whereas homozygous Leiden mice were not protected from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
